Group 1 - The core viewpoint is that Shanghai United Imaging Healthcare Co., Ltd. has received approval from the National Medical Products Administration (NMPA) for its photon-counting spectral CT, marking a significant breakthrough in China's medical technology sector and a major advancement in the "14th Five-Year Plan" key research and development project [1][2] - The photon-counting spectral CT has been installed in Fudan University Zhongshan Hospital and Shanghai Jiao Tong University School of Medicine Ruijin Hospital for clinical medical research [1] - Compared to traditional CT, the new technology features a reduction in detector pixel area to 1/9 of its original size, allowing for the visualization of finer pathological structures while maintaining image quality through innovative correction and reconstruction algorithms [1][2] Group 2 - The photon-counting spectral CT technology is recognized as a revolutionary direction for next-generation CT technology, with United Imaging leading the "14th Five-Year Plan" key research and development project in collaboration with various hospitals and institutions [2] - The company has made significant breakthroughs in core areas such as system design, algorithm innovation, and spectral applications, supported by its strong technical foundation and continuous investment in innovation [2] - The new CT technology significantly reduces radiation doses by 60% to 70%, and in some organs, it can lower the dose by 80% to 90%, enhancing patient safety during scans [1]
联影医疗:公司自主研发光子计数能谱CT获批上市